Integer Holdings Corp(ITGR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | 42.39 | EPS (ttm) | 2.99 | Insider Own | 14.6% | Shs Outstand | 34.0M | Perf Week | 0.04% |
| Market Cap | 4.30B | Forward P/E | 18.45 | EPS next Y | 11.5% | Insider Trans | -0.82% | Shs Float | 29.0M | Perf Month | 0.13% |
| Enterprise Value | 5.63B | PEG | 4.07 | EPS next Q | 1.78 | Inst Own | 119.74% | Short Float | 11.19% | Perf Quarter | 1.72% |
| Income | 0.10B | P/S | 2.36 | EPS this Y | -3.85% | Inst Trans | 4.72% | Short Ratio | 2.92 | Perf Half Y | 50.65% |
| Sales | 1.82B | P/B | 2.49 | EPS next 5Y | 4.53% | ROA | 3.05% | Short Interest | 3.25M | Perf YTD | 61.41% |
| Book/sh | 50.78 | P/C | 304.58 | EPS past 3/5Y | 13.83% 4.37% | ROE | 5.97% | 52W High | -0.19% ($126.83) | Perf Year | 99.92% |
| Cash/sh | 0.42 | P/FCF | 52.6 | Sales past 3/5Y | 10.24% 11.47% | ROIC | 3.39% | 52W Low | 104.18% ($62.00) | Perf 3Y | 57.45% |
| Dividend Est. | - | EV/EBITDA | 18.54 | EPS Y/Y TTM | 20.67% | Gross Margin | 22.09% | Volatility(W/M) | 0.14% 0.12% | Perf 5Y | 40.62% |
| Dividend TTM | - | EV/Sales | 3.09 | Sales Y/Y TTM | -0.33% | Oper. Margin | 9.03% | ATR (14) | 0.22 | Perf 10Y | 485.79% |
| Dividend Ex-Date | - | Quick Ratio | 2.6 | EPS Q/Q | -61.16% | Profit Margin | 5.69% | RSI (14) | 62.2 | Recom | 3.09 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.98 | Sales Q/Q | -3.63% | SMA20 | -0.01% ($126.6) | Beta | 0.6 | Target Price | $120.6 |
| Payout | - | Debt/Eq | 0.78 | Earnings | 2026/10/29 | SMA50 | 0.31% ($126.2) | Rel Volume | 0.51 | Prev Close | $126.52 |
| Employees | 11000 | LT Debt/Eq | 0.77 | EPS/Sales Surpr. | -20.3% -1.59% | SMA200 | 25.57% ($100.81) | Avg Volume(3M) | 1.11M | Price | $126.59 |
| IPO | 2000/9/29 | Option/Short | Yes/Yes | Trades | 3826 | Volume | 571,724 | Change | 0.06% |
🔧 This is a US medical device company that provides components and contract manufacturing for medical devices. It designs and manufactures components for cardiovascular and neuromodulation medical devices, as well as medical-grade batteries, supplying them to medical device companies, with exposure to the outsourcing demand in the medical device sector. It is a company operating in the medical device contract manufacturing field.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded less than usual. That is 51% of its average volume.
ITGR makes money exceptionally well
Of every $100 in sales, $9.03 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -3.9% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,854. Peers typically go for $1,688. It is about in line with its own 5-year average.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +40.6%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 119.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #22 of 142 in the industry
Based on market cap of $4B.
HAE#19 Haemonetics Corp $5B PER 58.4 
MMEDV#20 MiniMed Group Inc - When Issued - Oct 2026 $5B PER - 
LIVN#21 LivaNova PLC $4B PER 23.4 ITGR#22 Integer Holdings Corp $4B PER 42.4 
IRTC#23 iRhythm Holdings Inc $4B PER - 
FAQ
What kind of company is ITGR?
ITGR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ITGR?
The market cap of ITGR is approximately $4.3B, ranking 1,478 within its sector.
What is the P/E ratio of ITGR?
ITGR has a P/E ratio of approximately 42.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ITGR?
ITGR has recorded a 52-week high of $126.83 and a low of $62.00.
